Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 4.665
+0.070 (1.52%)
Mar 31, 2026, 5:00 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 69.22 million as of March 31, 2026. Its market cap has decreased by -36.65% in one year.
Market Cap
69.22M
Enterprise Value
63.95M
Revenue
15.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.67
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 69.22M, a decrease of -37.38%. That is a compound annual growth rate of -8.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 69.22M | 20.92% |
| Dec 30, 2025 | 57.25M | -45.34% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synektik Spólka Akcyjna | 2.29B |
| Medinice | 594.34M |
| Medicalgorithmics | 278.68M |
| Nestmedic | 27.38M |
| InventionMed | 20.08M |
| Adiuvo Investments | 8.30M |
| Milton Essex Spólka Akcyjna | 8.22M |
| Zortrax | 7.35M |